 | KalVista Pharmaceuticals, Inc. | |||
| NGM : KALV || Location: United States | ||||
$11.57+0.07 (+0.61%) |
0.05 M | 11.42 - 11.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 5.521 M |
| March 15, 2024 | 4.918 M |
| Feb. 29, 2024 | 4.507 M |
| Feb. 15, 2024 | 2.992 M |
| Jan. 31, 2024 | 2.473 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2024 | -0.78 | -0.84 | -7.35% |
| 12/31/2023 | -0.80 | -0.80 | 0.26% |
| 09/30/2023 | -0.88 | -0.74 | 15.49% |
| 06/30/2023 | -0.96 | -0.77 | 19.55% |
| 03/31/2023 | -1.00 | -0.75 | 25.35% |
KALV Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 42.188M | Shares Float | 24.117M |
| Short Float | 5.521M | Market Cap | 485.16M |
| Institution ownership | 92.16% | Insider ownership | 1.141% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -3.07 | Forward EPS | -2.44 |